These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32320205)

  • 41. Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.
    Paricharak S; Méndez-Lucio O; Chavan Ravindranath A; Bender A; IJzerman AP; van Westen GJP
    Brief Bioinform; 2018 Mar; 19(2):277-285. PubMed ID: 27789427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Docking of a novel DNA methyltransferase inhibitor identified from high-throughput screening: insights to unveil inhibitors in chemical databases.
    Medina-Franco JL; Yoo J
    Mol Divers; 2013 May; 17(2):337-44. PubMed ID: 23447100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Creating a more strategic small molecule biophysical hit characterization workflow.
    Fotsch C; Basu D; Case R; Chen Q; Koneru PC; Lo MC; Ngo R; Sharma P; Vaish A; Yi X; Zech SG; Hodder P
    SLAS Discov; 2024 Jun; 29(4):100159. PubMed ID: 38723666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predicting kinase inhibitors using bioactivity matrix derived informer sets.
    Zhang H; Ericksen SS; Lee CP; Ananiev GE; Wlodarchak N; Yu P; Mitchell JC; Gitter A; Wright SJ; Hoffmann FM; Wildman SA; Newton MA
    PLoS Comput Biol; 2019 Aug; 15(8):e1006813. PubMed ID: 31381559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
    Hua Y; Shun TY; Strock CJ; Johnston PA
    Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic Chemogenetic Library Assembly.
    Canham SM; Wang Y; Cornett A; Auld DS; Baeschlin DK; Patoor M; Skaanderup PR; Honda A; Llamas L; Wendel G; Mapa FA; Aspesi P; Labbé-Giguère N; Gamber GG; Palacios DS; Schuffenhauer A; Deng Z; Nigsch F; Frederiksen M; Bushell SM; Rothman D; Jain RK; Hemmerle H; Briner K; Porter JA; Tallarico JA; Jenkins JL
    Cell Chem Biol; 2020 Sep; 27(9):1124-1129. PubMed ID: 32707038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical Machine Learning: Virtual High-Throughput Screens Identifying Promising and Economical Small Molecule Inhibitors of Complement Factor C1s.
    Chen JJ; Schmucker LN; Visco DP
    Biomolecules; 2018 May; 8(2):. PubMed ID: 29735903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.
    Mady ASA; Liao C; Bajwa N; Kump KJ; Abulwerdi FA; Lev KL; Miao L; Grigsby SM; Perdih A; Stuckey JA; Du Y; Fu H; Nikolovska-Coleska Z
    Sci Rep; 2018 Jul; 8(1):10210. PubMed ID: 29976942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein-Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery.
    Milhas S; Raux B; Betzi S; Derviaux C; Roche P; Restouin A; Basse MJ; Rebuffet E; Lugari A; Badol M; Kashyap R; Lissitzky JC; Eydoux C; Hamon V; Gourdel ME; Combes S; Zimmermann P; Aurrand-Lions M; Roux T; Rogers C; Müller S; Knapp S; Trinquet E; Collette Y; Guillemot JC; Morelli X
    ACS Chem Biol; 2016 Aug; 11(8):2140-8. PubMed ID: 27219844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AI-Powered Virtual Screening of Large Compound Libraries Leads to the Discovery of Novel Inhibitors of Sirtuin-1.
    Gryniukova A; Kaiser F; Myziuk I; Alieksieieva D; Leberecht C; Heym PP; Tarkhanova OO; Moroz YS; Borysko P; Haupt VJ
    J Med Chem; 2023 Aug; 66(15):10241-10251. PubMed ID: 37499195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.
    Xiao T; Qi X; Chen Y; Jiang Y
    Mol Inform; 2018 Nov; 37(11):e1800031. PubMed ID: 29882343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive peptidomimetic libraries targeting protein-protein interactions.
    Whitby LR; Boger DL
    Acc Chem Res; 2012 Oct; 45(10):1698-709. PubMed ID: 22799570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometry.
    Curpan RF; Simons PC; Zhai D; Young SM; Carter MB; Bologa CG; Oprea TI; Satterthwait AC; Reed JC; Edwards BS; Sklar LA
    Assay Drug Dev Technol; 2011 Oct; 9(5):465-74. PubMed ID: 21561376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemical and biological properties of frequent screening hits.
    Che J; King FJ; Zhou B; Zhou Y
    J Chem Inf Model; 2012 Apr; 52(4):913-26. PubMed ID: 22435989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Achievements, Challenges, and Opportunities in DNA-Encoded Library Research: An Academic Point of View.
    Yuen LH; Franzini RM
    Chembiochem; 2017 May; 18(9):829-836. PubMed ID: 28032411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors.
    Xue X; Wei JL; Xu LL; Xi MY; Xu XL; Liu F; Guo XK; Wang L; Zhang XJ; Zhang MY; Lu MC; Sun HP; You QD
    J Chem Inf Model; 2013 Oct; 53(10):2715-29. PubMed ID: 24050442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benefits of Strategic Small-Scale Targeted Screening.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Aug; 14(6):329-32. PubMed ID: 27341343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell Painting-based bioactivity prediction boosts high-throughput screening hit-rates and compound diversity.
    Fredin Haslum J; Lardeau CH; Karlsson J; Turkki R; Leuchowius KJ; Smith K; Müllers E
    Nat Commun; 2024 Apr; 15(1):3470. PubMed ID: 38658534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.